Global 3D Cell Cultures Market

3D Cell Cultures Comprehensive Study by Type (Membrane Type, Foam / gel Type, Microcarriers Type), Application (Tissue Engineering, Tumor Model, Stem Cell Research, Drug Discovery, Regenerative Medicine), End users (Biotechnology and pharmaceutical industries, Research laboratories and institutes, Hospitals and diagnostic centers, Others), Technology (Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates), Scaffold-Free (Hanging drop microplates, Spheroid microplates containing Ultra Low Attachment (ULA) coating), Microfluidic 3D cell culture, Magnetic levitation & 3D bioprinting), 3D Bioreactors), Component (Media, Reagents and Consumables) Players and Region - Global Market Outlook to 2027

3D Cell Cultures Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 12.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global 3D Cell Cultures Market Overview:
3D cell culture is an in vitro technique where cells are grown in an artificially created environment, which resembles the in vivo environment. This technique stimulates the normal cell to differentiate, proliferate, and migrate by interacting with their three-dimensional surroundings. 3D cell culture nurtures levels of cell differentiation and tissue organization which is not viable in traditional 2D culture systems. The Technique has more tissue divergence and cell cohesion properties. Cell studies have evolved from being performed on 2D surfaces to a 3D configuration to mimic more closely their natural 3D habitat in the body which is referred to 3D cell culture. A number of Research Organizations and leading market companies are increasing investment in 3D cell culture, thereby fueling the market for 3D cell culture technique on a Global level. As per latest AMA study, the Global 3D Cell Cultures market is expected to see growth rate of 12.8%

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies ProfiledMerck Sharp & Dohme Corp. (United States), Sigma Corporation (Japan), Lonza Group (Switzerland), 3D Biomatrix (United States), Ams Biotechnology (United Kingdom), Life Technologies Corporation (United States), Microtissues Inc. (United States), Labome.Org (United States), Tecan Group Ltd. (Switzerland), Lena BioSciences (United States) and 3D Biotek (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • Increasing Adoption of Tissue Engineering and Organ Transplantation for Chronic Diseases
  • Focus on Developing Alternatives for Animal Testing
  • Technological Advancement and Product Launch

Roadblocks
  • Lack of Consistency in 3D Cell Culture Technique

Opportunities
  • The Superiority of 3D over 2D Cell Culture Technique
  • The Emergence of 3D BioPrinting Technology in Tissue Engineering and Regenerative Medicine

Challenges
  • Financial Challenges by Small and Medium-Sized Laboratories
  • Initial Investment in Establishing 3D Cell Culture is Expensive


Competitive Landscape:
The market is fragmented with major players focused on collaborating with laboratories to commercialize technologies that are not potentially established in the market space. Various Government Organizations and Private companies, and Pharmaceutical and analytical instrumental companies have largely invested in the 3D cell culture projects to meet the demand of the novel drug discoveries and organs development.
Some of the key players profiled in the report are Merck Sharp & Dohme Corp. (United States), Sigma Corporation (Japan), Lonza Group (Switzerland), 3D Biomatrix (United States), Ams Biotechnology (United Kingdom), Life Technologies Corporation (United States), Microtissues Inc. (United States), Labome.Org (United States), Tecan Group Ltd. (Switzerland), Lena BioSciences (United States) and 3D Biotek (United States). Additionally, following companies can also be profiled that are part of our coverage like Nano 3D Biosciences, Inc. (United States), Scivax Life Sciences (Japan), Corning Incorporated (United States), ThermoScientific Inc.(United States) and ReproCELL (Japan). Analyst at AMA Research see United States Players to retain maximum share of Global 3D Cell Cultures market by 2027. Considering Market by End users, the sub-segment i.e. Biotechnology and pharmaceutical industries will boost the 3D Cell Cultures market. Considering Market by Technology, the sub-segment i.e. Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates) will boost the 3D Cell Cultures market. Considering Market by Component, the sub-segment i.e. Media will boost the 3D Cell Cultures market.

BioTek’s Lionheart FX and Cytation, along with Gen5 3.0 offer countless tools for imaging and analyzing 3D culture methods. Objective magnifications from 1.25x to 60x, multiple color channels, four unique modes of detection and processes such as image z-stacking, z-projections, montage mode, and image stitching provide a comprehensive solution for assays run with 3D cell culture methods.

What Can be Explored with the 3D Cell Cultures Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global 3D Cell Cultures Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in 3D Cell Cultures
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global 3D Cell Cultures market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in 3D Cell Cultures market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes 3D Cell Culture Products, Pharmaceutical and Biotechnology companies, Research and Development Companies, Research Institutes, Research and Consulting firms and Venture capitalists.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Membrane Type
  • Foam / gel Type
  • Microcarriers Type
By Application
  • Tissue Engineering
  • Tumor Model
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
By End users
  • Biotechnology and pharmaceutical industries
  • Research laboratories and institutes
  • Hospitals and diagnostic centers
  • Others

By Technology
  • Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates)
  • Scaffold-Free (Hanging drop microplates, Spheroid microplates containing Ultra Low Attachment (ULA) coating), Microfluidic 3D cell culture, Magnetic levitation & 3D bioprinting)
  • 3D Bioreactors

By Component
  • Media
  • Reagents and Consumables

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of Tissue Engineering and Organ Transplantation for Chronic Diseases
      • 3.2.2. Focus on Developing Alternatives for Animal Testing
      • 3.2.3. Technological Advancement and Product Launch
    • 3.3. Market Challenges
      • 3.3.1. Financial Challenges by Small and Medium-Sized Laboratories
      • 3.3.2. Initial Investment in Establishing 3D Cell Culture is Expensive
    • 3.4. Market Trends
      • 3.4.1. Use of Microchips to Implement Culturing through Use of Micro-fabricated Tissue Component
      • 3.4.2. Government Investments for Healthcare Due To Increased Risk of Diseases Such As Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global 3D Cell Cultures, by Type, Application, End users, Technology, Component and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global 3D Cell Cultures (Value)
      • 5.2.1. Global 3D Cell Cultures by: Type (Value)
        • 5.2.1.1. Membrane Type
        • 5.2.1.2. Foam / gel Type
        • 5.2.1.3. Microcarriers Type
      • 5.2.2. Global 3D Cell Cultures by: Application (Value)
        • 5.2.2.1. Tissue Engineering
        • 5.2.2.2. Tumor Model
        • 5.2.2.3. Stem Cell Research
        • 5.2.2.4. Drug Discovery
        • 5.2.2.5. Regenerative Medicine
      • 5.2.3. Global 3D Cell Cultures by: End users (Value)
        • 5.2.3.1. Biotechnology and pharmaceutical industries
        • 5.2.3.2. Research laboratories and institutes
        • 5.2.3.3. Hospitals and diagnostic centers
        • 5.2.3.4. Others
      • 5.2.4. Global 3D Cell Cultures by: Technology (Value)
        • 5.2.4.1. Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates)
        • 5.2.4.2. Scaffold-Free (Hanging drop microplates, Spheroid microplates containing Ultra Low Attachment (ULA) coating), Microfluidic 3D cell culture, Magnetic levitation & 3D bioprinting)
        • 5.2.4.3. 3D Bioreactors
      • 5.2.5. Global 3D Cell Cultures by: Component (Value)
        • 5.2.5.1. Media
        • 5.2.5.2. Reagents and Consumables
      • 5.2.6. Global 3D Cell Cultures Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. 3D Cell Cultures: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck Sharp & Dohme Corp. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sigma Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lonza Group (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. 3D Biomatrix (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ams Biotechnology (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Life Technologies Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Microtissues Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Labome.Org (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tecan Group Ltd. (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lena BioSciences (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. 3D Biotek (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global 3D Cell Cultures Sale, by Type, Application, End users, Technology, Component and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global 3D Cell Cultures (Value)
      • 7.2.1. Global 3D Cell Cultures by: Type (Value)
        • 7.2.1.1. Membrane Type
        • 7.2.1.2. Foam / gel Type
        • 7.2.1.3. Microcarriers Type
      • 7.2.2. Global 3D Cell Cultures by: Application (Value)
        • 7.2.2.1. Tissue Engineering
        • 7.2.2.2. Tumor Model
        • 7.2.2.3. Stem Cell Research
        • 7.2.2.4. Drug Discovery
        • 7.2.2.5. Regenerative Medicine
      • 7.2.3. Global 3D Cell Cultures by: End users (Value)
        • 7.2.3.1. Biotechnology and pharmaceutical industries
        • 7.2.3.2. Research laboratories and institutes
        • 7.2.3.3. Hospitals and diagnostic centers
        • 7.2.3.4. Others
      • 7.2.4. Global 3D Cell Cultures by: Technology (Value)
        • 7.2.4.1. Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates)
        • 7.2.4.2. Scaffold-Free (Hanging drop microplates, Spheroid microplates containing Ultra Low Attachment (ULA) coating), Microfluidic 3D cell culture, Magnetic levitation & 3D bioprinting)
        • 7.2.4.3. 3D Bioreactors
      • 7.2.5. Global 3D Cell Cultures by: Component (Value)
        • 7.2.5.1. Media
        • 7.2.5.2. Reagents and Consumables
      • 7.2.6. Global 3D Cell Cultures Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. 3D Cell Cultures: by Type(USD Million)
  • Table 2. 3D Cell Cultures Membrane Type , by Region USD Million (2016-2021)
  • Table 3. 3D Cell Cultures Foam / gel Type , by Region USD Million (2016-2021)
  • Table 4. 3D Cell Cultures Microcarriers Type , by Region USD Million (2016-2021)
  • Table 5. 3D Cell Cultures: by Application(USD Million)
  • Table 6. 3D Cell Cultures Tissue Engineering , by Region USD Million (2016-2021)
  • Table 7. 3D Cell Cultures Tumor Model , by Region USD Million (2016-2021)
  • Table 8. 3D Cell Cultures Stem Cell Research , by Region USD Million (2016-2021)
  • Table 9. 3D Cell Cultures Drug Discovery , by Region USD Million (2016-2021)
  • Table 10. 3D Cell Cultures Regenerative Medicine , by Region USD Million (2016-2021)
  • Table 11. 3D Cell Cultures: by End users(USD Million)
  • Table 12. 3D Cell Cultures Biotechnology and pharmaceutical industries , by Region USD Million (2016-2021)
  • Table 13. 3D Cell Cultures Research laboratories and institutes , by Region USD Million (2016-2021)
  • Table 14. 3D Cell Cultures Hospitals and diagnostic centers , by Region USD Million (2016-2021)
  • Table 15. 3D Cell Cultures Others , by Region USD Million (2016-2021)
  • Table 16. 3D Cell Cultures: by Technology(USD Million)
  • Table 17. 3D Cell Cultures Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates) , by Region USD Million (2016-2021)
  • Table 18. 3D Cell Cultures Scaffold-Free (Hanging drop microplates, Spheroid microplates containing Ultra Low Attachment (ULA) coating), Microfluidic 3D cell culture, Magnetic levitation & 3D bioprinting) , by Region USD Million (2016-2021)
  • Table 19. 3D Cell Cultures 3D Bioreactors , by Region USD Million (2016-2021)
  • Table 20. 3D Cell Cultures: by Component(USD Million)
  • Table 21. 3D Cell Cultures Media , by Region USD Million (2016-2021)
  • Table 22. 3D Cell Cultures Reagents and Consumables , by Region USD Million (2016-2021)
  • Table 23. South America 3D Cell Cultures, by Country USD Million (2016-2021)
  • Table 24. South America 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 25. South America 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 26. South America 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 27. South America 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 28. South America 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 29. Brazil 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 30. Brazil 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 31. Brazil 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 32. Brazil 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 33. Brazil 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 34. Argentina 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 35. Argentina 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 36. Argentina 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 37. Argentina 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 38. Argentina 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 39. Rest of South America 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 40. Rest of South America 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 41. Rest of South America 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 42. Rest of South America 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 43. Rest of South America 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 44. Asia Pacific 3D Cell Cultures, by Country USD Million (2016-2021)
  • Table 45. Asia Pacific 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 46. Asia Pacific 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 47. Asia Pacific 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 48. Asia Pacific 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 49. Asia Pacific 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 50. China 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 51. China 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 52. China 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 53. China 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 54. China 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 55. Japan 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 56. Japan 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 57. Japan 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 58. Japan 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 59. Japan 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 60. India 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 61. India 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 62. India 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 63. India 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 64. India 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 65. South Korea 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 66. South Korea 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 67. South Korea 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 68. South Korea 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 69. South Korea 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 70. Taiwan 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 71. Taiwan 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 72. Taiwan 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 73. Taiwan 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 74. Taiwan 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 75. Australia 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 76. Australia 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 77. Australia 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 78. Australia 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 79. Australia 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 84. Rest of Asia-Pacific 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 85. Europe 3D Cell Cultures, by Country USD Million (2016-2021)
  • Table 86. Europe 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 87. Europe 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 88. Europe 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 89. Europe 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 90. Europe 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 91. Germany 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 92. Germany 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 93. Germany 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 94. Germany 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 95. Germany 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 96. France 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 97. France 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 98. France 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 99. France 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 100. France 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 101. Italy 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 102. Italy 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 103. Italy 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 104. Italy 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 105. Italy 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 106. United Kingdom 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 107. United Kingdom 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 108. United Kingdom 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 109. United Kingdom 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 110. United Kingdom 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 111. Netherlands 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 112. Netherlands 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 113. Netherlands 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 114. Netherlands 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 115. Netherlands 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 116. Rest of Europe 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 117. Rest of Europe 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 118. Rest of Europe 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 119. Rest of Europe 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 120. Rest of Europe 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 121. MEA 3D Cell Cultures, by Country USD Million (2016-2021)
  • Table 122. MEA 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 123. MEA 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 124. MEA 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 125. MEA 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 126. MEA 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 127. Middle East 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 128. Middle East 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 129. Middle East 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 130. Middle East 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 131. Middle East 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 132. Africa 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 133. Africa 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 134. Africa 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 135. Africa 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 136. Africa 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 137. North America 3D Cell Cultures, by Country USD Million (2016-2021)
  • Table 138. North America 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 139. North America 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 140. North America 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 141. North America 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 142. North America 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 143. United States 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 144. United States 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 145. United States 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 146. United States 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 147. United States 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 148. Canada 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 149. Canada 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 150. Canada 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 151. Canada 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 152. Canada 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 153. Mexico 3D Cell Cultures, by Type USD Million (2016-2021)
  • Table 154. Mexico 3D Cell Cultures, by Application USD Million (2016-2021)
  • Table 155. Mexico 3D Cell Cultures, by End users USD Million (2016-2021)
  • Table 156. Mexico 3D Cell Cultures, by Technology USD Million (2016-2021)
  • Table 157. Mexico 3D Cell Cultures, by Component USD Million (2016-2021)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. 3D Cell Cultures: by Type(USD Million)
  • Table 170. 3D Cell Cultures Membrane Type , by Region USD Million (2022-2027)
  • Table 171. 3D Cell Cultures Foam / gel Type , by Region USD Million (2022-2027)
  • Table 172. 3D Cell Cultures Microcarriers Type , by Region USD Million (2022-2027)
  • Table 173. 3D Cell Cultures: by Application(USD Million)
  • Table 174. 3D Cell Cultures Tissue Engineering , by Region USD Million (2022-2027)
  • Table 175. 3D Cell Cultures Tumor Model , by Region USD Million (2022-2027)
  • Table 176. 3D Cell Cultures Stem Cell Research , by Region USD Million (2022-2027)
  • Table 177. 3D Cell Cultures Drug Discovery , by Region USD Million (2022-2027)
  • Table 178. 3D Cell Cultures Regenerative Medicine , by Region USD Million (2022-2027)
  • Table 179. 3D Cell Cultures: by End users(USD Million)
  • Table 180. 3D Cell Cultures Biotechnology and pharmaceutical industries , by Region USD Million (2022-2027)
  • Table 181. 3D Cell Cultures Research laboratories and institutes , by Region USD Million (2022-2027)
  • Table 182. 3D Cell Cultures Hospitals and diagnostic centers , by Region USD Million (2022-2027)
  • Table 183. 3D Cell Cultures Others , by Region USD Million (2022-2027)
  • Table 184. 3D Cell Cultures: by Technology(USD Million)
  • Table 185. 3D Cell Cultures Scaffold (Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates) , by Region USD Million (2022-2027)
  • Table 186. 3D Cell Cultures Scaffold-Free (Hanging drop microplates, Spheroid microplates containing Ultra Low Attachment (ULA) coating), Microfluidic 3D cell culture, Magnetic levitation & 3D bioprinting) , by Region USD Million (2022-2027)
  • Table 187. 3D Cell Cultures 3D Bioreactors , by Region USD Million (2022-2027)
  • Table 188. 3D Cell Cultures: by Component(USD Million)
  • Table 189. 3D Cell Cultures Media , by Region USD Million (2022-2027)
  • Table 190. 3D Cell Cultures Reagents and Consumables , by Region USD Million (2022-2027)
  • Table 191. South America 3D Cell Cultures, by Country USD Million (2022-2027)
  • Table 192. South America 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 193. South America 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 194. South America 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 195. South America 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 196. South America 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 197. Brazil 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 198. Brazil 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 199. Brazil 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 200. Brazil 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 201. Brazil 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 202. Argentina 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 203. Argentina 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 204. Argentina 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 205. Argentina 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 206. Argentina 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 207. Rest of South America 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 208. Rest of South America 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 209. Rest of South America 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 210. Rest of South America 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 211. Rest of South America 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 212. Asia Pacific 3D Cell Cultures, by Country USD Million (2022-2027)
  • Table 213. Asia Pacific 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 214. Asia Pacific 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 215. Asia Pacific 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 216. Asia Pacific 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 217. Asia Pacific 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 218. China 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 219. China 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 220. China 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 221. China 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 222. China 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 223. Japan 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 224. Japan 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 225. Japan 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 226. Japan 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 227. Japan 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 228. India 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 229. India 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 230. India 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 231. India 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 232. India 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 233. South Korea 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 234. South Korea 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 235. South Korea 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 236. South Korea 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 237. South Korea 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 238. Taiwan 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 239. Taiwan 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 240. Taiwan 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 241. Taiwan 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 242. Taiwan 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 243. Australia 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 244. Australia 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 245. Australia 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 246. Australia 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 247. Australia 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 248. Rest of Asia-Pacific 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 249. Rest of Asia-Pacific 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 250. Rest of Asia-Pacific 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 251. Rest of Asia-Pacific 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 252. Rest of Asia-Pacific 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 253. Europe 3D Cell Cultures, by Country USD Million (2022-2027)
  • Table 254. Europe 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 255. Europe 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 256. Europe 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 257. Europe 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 258. Europe 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 259. Germany 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 260. Germany 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 261. Germany 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 262. Germany 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 263. Germany 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 264. France 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 265. France 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 266. France 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 267. France 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 268. France 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 269. Italy 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 270. Italy 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 271. Italy 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 272. Italy 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 273. Italy 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 274. United Kingdom 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 275. United Kingdom 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 276. United Kingdom 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 277. United Kingdom 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 278. United Kingdom 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 279. Netherlands 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 280. Netherlands 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 281. Netherlands 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 282. Netherlands 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 283. Netherlands 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 284. Rest of Europe 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 285. Rest of Europe 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 286. Rest of Europe 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 287. Rest of Europe 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 288. Rest of Europe 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 289. MEA 3D Cell Cultures, by Country USD Million (2022-2027)
  • Table 290. MEA 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 291. MEA 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 292. MEA 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 293. MEA 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 294. MEA 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 295. Middle East 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 296. Middle East 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 297. Middle East 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 298. Middle East 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 299. Middle East 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 300. Africa 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 301. Africa 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 302. Africa 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 303. Africa 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 304. Africa 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 305. North America 3D Cell Cultures, by Country USD Million (2022-2027)
  • Table 306. North America 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 307. North America 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 308. North America 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 309. North America 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 310. North America 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 311. United States 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 312. United States 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 313. United States 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 314. United States 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 315. United States 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 316. Canada 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 317. Canada 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 318. Canada 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 319. Canada 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 320. Canada 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 321. Mexico 3D Cell Cultures, by Type USD Million (2022-2027)
  • Table 322. Mexico 3D Cell Cultures, by Application USD Million (2022-2027)
  • Table 323. Mexico 3D Cell Cultures, by End users USD Million (2022-2027)
  • Table 324. Mexico 3D Cell Cultures, by Technology USD Million (2022-2027)
  • Table 325. Mexico 3D Cell Cultures, by Component USD Million (2022-2027)
  • Table 326. Research Programs/Design for This Report
  • Table 327. Key Data Information from Secondary Sources
  • Table 328. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global 3D Cell Cultures: by Type USD Million (2016-2021)
  • Figure 5. Global 3D Cell Cultures: by Application USD Million (2016-2021)
  • Figure 6. Global 3D Cell Cultures: by End users USD Million (2016-2021)
  • Figure 7. Global 3D Cell Cultures: by Technology USD Million (2016-2021)
  • Figure 8. Global 3D Cell Cultures: by Component USD Million (2016-2021)
  • Figure 9. South America 3D Cell Cultures Share (%), by Country
  • Figure 10. Asia Pacific 3D Cell Cultures Share (%), by Country
  • Figure 11. Europe 3D Cell Cultures Share (%), by Country
  • Figure 12. MEA 3D Cell Cultures Share (%), by Country
  • Figure 13. North America 3D Cell Cultures Share (%), by Country
  • Figure 14. Global 3D Cell Cultures share by Players 2021 (%)
  • Figure 15. Global 3D Cell Cultures share by Players (Top 3) 2021(%)
  • Figure 16. Global 3D Cell Cultures share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Merck Sharp & Dohme Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Merck Sharp & Dohme Corp. (United States) Revenue: by Geography 2021
  • Figure 20. Sigma Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Sigma Corporation (Japan) Revenue: by Geography 2021
  • Figure 22. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Lonza Group (Switzerland) Revenue: by Geography 2021
  • Figure 24. 3D Biomatrix (United States) Revenue, Net Income and Gross profit
  • Figure 25. 3D Biomatrix (United States) Revenue: by Geography 2021
  • Figure 26. Ams Biotechnology (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Ams Biotechnology (United Kingdom) Revenue: by Geography 2021
  • Figure 28. Life Technologies Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Life Technologies Corporation (United States) Revenue: by Geography 2021
  • Figure 30. Microtissues Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Microtissues Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Labome.Org (United States) Revenue, Net Income and Gross profit
  • Figure 33. Labome.Org (United States) Revenue: by Geography 2021
  • Figure 34. Tecan Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Tecan Group Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 36. Lena BioSciences (United States) Revenue, Net Income and Gross profit
  • Figure 37. Lena BioSciences (United States) Revenue: by Geography 2021
  • Figure 38. 3D Biotek (United States) Revenue, Net Income and Gross profit
  • Figure 39. 3D Biotek (United States) Revenue: by Geography 2021
  • Figure 40. Global 3D Cell Cultures: by Type USD Million (2022-2027)
  • Figure 41. Global 3D Cell Cultures: by Application USD Million (2022-2027)
  • Figure 42. Global 3D Cell Cultures: by End users USD Million (2022-2027)
  • Figure 43. Global 3D Cell Cultures: by Technology USD Million (2022-2027)
  • Figure 44. Global 3D Cell Cultures: by Component USD Million (2022-2027)
  • Figure 45. South America 3D Cell Cultures Share (%), by Country
  • Figure 46. Asia Pacific 3D Cell Cultures Share (%), by Country
  • Figure 47. Europe 3D Cell Cultures Share (%), by Country
  • Figure 48. MEA 3D Cell Cultures Share (%), by Country
  • Figure 49. North America 3D Cell Cultures Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck Sharp & Dohme Corp. (United States)
  • Sigma Corporation (Japan)
  • Lonza Group (Switzerland)
  • 3D Biomatrix (United States)
  • Ams Biotechnology (United Kingdom)
  • Life Technologies Corporation (United States)
  • Microtissues Inc. (United States)
  • Labome.Org (United States)
  • Tecan Group Ltd. (Switzerland)
  • Lena BioSciences (United States)
  • 3D Biotek (United States)
Additional players considered in the study are as follows:
Nano 3D Biosciences, Inc. (United States) , Scivax Life Sciences (Japan) , Corning Incorporated (United States) , ThermoScientific Inc.(United States) , ReproCELL (Japan)
Select User Access Type

Key Highlights of Report


May 2022 238 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global 3D Cell Cultures Market Quantitative research analysis
Global 3D Cell Cultures Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global 3D Cell Cultures market are Merck Sharp & Dohme Corp. (United States), Sigma Corporation (Japan), Lonza Group (Switzerland), 3D Biomatrix (United States), Ams Biotechnology (United Kingdom), Life Technologies Corporation (United States), Microtissues Inc. (United States), Labome.Org (United States), Tecan Group Ltd. (Switzerland), Lena BioSciences (United States) and 3D Biotek (United States), to name a few.
"Use of Microchips to Implement Culturing through Use of Micro-fabricated Tissue Component " is seen as one of major influencing trends for 3D Cell Cultures Market during projected period 2021-2027.

Know More About Global 3D Cell Cultures Market Report?

Have a Query? Click Here

Other Related Reports

Medical Biomimetics Comprehensive Study by Type (Cardiovascular, Orthopedic (Prostheses, Exoskeleton), Ophthalmology, Dental, Others), Application (Wound Healing, Tissue Engineering, Drug Delivery, P...
$ 3350
Antimicrobial Susceptibility Testing Comprehensive Study by Type (Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility T...
$ 3750
Peptides Comprehensive Study by Type (Custom (Standard , Quant , Cyclic Custom , Others), Catalog (Neuroscience, Cardiovascular, Diabetes, Others)), Application (Commercial, Academic Research, Therap...
$ 3450
DNA and Gene Chip Comprehensive Study by Type (Oligonucleotide Based Chips {Photolithographic Oligonucleotide Chips, Inkjet Print Technology Generated Oligonucleotide Chips}, CDNA Chips {Mechanical M...
$ 3750
Extremity Tissue Expander Comprehensive Study by Type (Upper extremities, Lower extremities), Application (Breast reconstruction, Scalp reconstruction, Oral and maxillofacial reconstruction, Paediatr...
$ 3650
Antibiotic Resistance Comprehensive Study by Disease (Complicated Urinary Tract Infection {cUTI}, Complicated Intra-Abdominal Infections {cIAI}, Blood Stream Infections {BSI}, Clostridium difficile i...
$ 3750